Search for: "Belcher Pharmaceuticals, LLC v. Hospira, Inc." Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Pom Wonderful applies to pharmaceuticals, but "implied FDA approval" claim still fails
30 Aug 2021, 10:13 am by Rebecca Tushnet
Belcher Pharms., LLC v. [read post]
43(B)log - http://tushnet.blogspot.com/
Inconsistent Statements to USPTO and FDA May Render Patents Unenforceable
10 Nov 2021, 3:08 am by Charlotte Jacobsen (Ropes & Gray LLP), Filko Prugo (Ropes & Gray LLP) and Jon Tanaka (Ropes & Gray LLP)
Hospira, Inc.,[1]Belcher Pharms., LLC v. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Rx label and database linkages plausibly deceive consumers; mostly not precluded by FDCA
7 Feb 2022, 10:32 am by Rebecca Tushnet
“In Belcher Pharmaceuticals, LLC v. [read post]
43(B)log - http://tushnet.blogspot.com/
USPTO Underscores Duty of Disclosure Pertaining To FDA Submissions
8 Aug 2022, 7:11 am by Courtenay C. Brinckerhoff
Hospira, Inc., 11 F.4th 1345 (Fed. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents
The Intersection Of Patent Law And Regulatory Strategy For Medical Device Companies
11 Mar 2025, 1:59 am by Jake Ward
March 4, 2025 | Expert Insights | Authored by Accorto Regulatory Solutions & Ward Law Office Inventors of new medical technologies often face a myriad of decisions when beginning the process of bringing these new technologies to market. [read post]
ANTICIPATETHIS.com - http://anticipatethis.wordpress.com